Moderna, Inc.
MRNA · Healthcare · · USDFahodi Score BUY Mid-term (Position)
77
/ 100
Technical
100
Trend & RS
100
Momentum
90
Fundamental
61
Macro
24
Liquidity
46
| Component | Score | Weight |
|---|---|---|
| Technical | 100.0 | 20% |
| Trend & RS | 100.0 | 30% |
| Momentum | 90.5 | 15% |
| Fundamental | 61.1 | 10% |
| Macro | 23.6 | 20% |
| Liquidity | 45.5 | 5% |
Trade Setup
| Entry | 241.46 |
| Stop Loss | 201.06 (16.7%) |
| Target 1 (1:1) | 281.86 (+16.7%) |
| Target 2 (2:1) | 322.26 (+33.5%) |
| ATR(14) | 20.20 (8.4%) |
| Risk per Share | 40.40 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 0.0 | -2.00 | |
| Momentum | 90.5 | +1.62 | |
| Quality | 17.1 | -1.32 | |
| Composite | 35.9 | ||
Quality Scores
Piotroski F-Score
2
/9 —
Weak
✗
✗
✗
✗
✓
✓
✗
✗
✗
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
45.89
—
Safe Zone
Distress <1.81Grey 1.81–2.99>2.99 Safe
Valuation vs Peers Overvalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | N/A | 22.0 | Inline |
| P/B Ratio | 14.2 | 4.0 | Above |
| Dividend Yield | 0.0% | 1.5% | Below avg |
Comparing against Healthcare median multiples.
Trading at a premium to sector peers — verify growth justifies premium.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
49.66%
Full Kelly
24.83%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 77/100. Estimated win rate 63%, avg win 9.6%, avg loss 3.5%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
4
Bullish Signals
0
Bearish Signals
60.39
RSI(14)
13.2249
MACD
Relative Strength (RS) IMPROVING
99
/ 99
RS Rating
✓ O'Neil PASS (≥80)
| RS vs SPY | ↑ RISING (+313.1% vs SPY 3M) |
| RS vs Sector | OUTPERFORMING (Healthcare) |
| RS New High | No (1d since high) |
| Sector Outperformance | +295.1% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
IMPROVING:
Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 60.39 | NEUTRAL |
| Macd | 13.2249 | BULLISH |
| Ma Cross | 189.62 / 90.46 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.69x | NORMAL |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 261.00 |
| Bollinger Upper | 254.87 |
| SMA(200) | 90.46 |
| SMA(50) | 189.62 |
| SMA(20) | 223.39 |
| Current Price | 241.46 |
| Bollinger Lower | 191.92 |
| 52-Week Low | 22.28 |
| ATR(14) | 20.2 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
MARKUP
Confidence
100%
Acc: 0.0 |
Dist: 0.0 |
Markup: 2.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-10-30 | Normal | 0.52x | Normal bar — no special VSA pattern |
| 2026-11-02 | No Demand | 0.49x | Low volume, narrow spread, weak close — no buying interest |
| 2026-11-03 | Normal | 0.55x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 0.86x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 0.69x | Normal bar — no special VSA pattern |
Ichimoku Cloud BULLISH
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 220.26 | Below Kijun |
| Kijun-sen (26) | 220.26 | Base line |
| Senkou A | 220.26 | Leading span A |
| Senkou B | 195.69 | Leading span B |
| Cloud | 195.69 – 220.26 | Bullish (Green) |
| Price vs Cloud | 241.46 | Above Cloud |
| Chikou Span | 188.94 | Bullish |
| Alignment Score | 3/4 | BULLISH |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE ON
5 bars
Momentum:
BULLISH FADING
BB: 191.92 – 254.87 | KC: 189.59 – 257.2
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Hidden Bullish | RSI | 9 | |
| Hidden Bullish | MACD | 9 | |
| Regular Bearish | RSI | 12 | |
| Hidden Bullish | RSI | 23 |
Anchored VWAP
VWAP: 105.20
Anchor: 2025-11-21 (52w Low)
ABOVE AVWAP
+129.5%
Heikin-Ashi Trend
BULLISH
Full data via /api/advanced/MRNA
Valuation
| Metric | Value |
|---|---|
| Market Cap | 96.40B |
| P/E (TTM) | N/A |
| Forward P/E | N/A |
| P/B | 14.25 |
| EPS | -7.98 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 2.1% |
| Profit Margin | -1.4% |
| ROE | -39.0% |
| Debt/Equity | 19.04 |
| Current Ratio | 2.29 |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Beta | 1.17 |
Trading Data
241.46
Open
241.46
Day High
241.46
Day Low
11.88M
Volume (0.5x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)